224 related items for PubMed ID: 21928226
1. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
2. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
3. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
[Abstract] [Full Text] [Related]
4. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
5. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
6. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
7. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
Yoshikawa N, Ito H, Takekoshi Y, Honda M, Awazu M, Iijima K, Nakamura H, Seino Y, Takeda N, Hattori S, Matsuda I.
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):587-90. PubMed ID: 9893457
[Abstract] [Full Text] [Related]
8. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
Simmonds J, Grundy N, Trompeter R, Tullus K.
Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
[Abstract] [Full Text] [Related]
9. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
10. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V, Krishnamurthy S, Harichandrakumar KT.
Pediatr Nephrol; 2016 Apr; 31(4):595-604. PubMed ID: 26759000
[Abstract] [Full Text] [Related]
11. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
12. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
Fu LS, Shien CY, Chi CS.
Nephron Clin Pract; 2004 Apr; 97(4):c137-41. PubMed ID: 15331936
[Abstract] [Full Text] [Related]
13. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
14. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS, Trompeter RS.
Arch Dis Child; 2008 Mar; 93(3):226-8. PubMed ID: 17573408
[Abstract] [Full Text] [Related]
15. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
16. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
Mymensingh Med J; 2014 Apr 23; 23(2):261-7. PubMed ID: 24858152
[Abstract] [Full Text] [Related]
17. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
Nephrol Dial Transplant; 2007 Aug 23; 22(8):2183-93. PubMed ID: 17504846
[Abstract] [Full Text] [Related]
18. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
Kidney Int; 2012 Nov 23; 82(10):1130-5. PubMed ID: 22763815
[Abstract] [Full Text] [Related]
19. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F, Ahmed TM, Samina U.
J Coll Physicians Surg Pak; 2006 Jan 23; 16(1):35-7. PubMed ID: 16441986
[Abstract] [Full Text] [Related]
20. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug 23; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
